4 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... recommendations in renal ... #Diabetic #Medications ... Dosing #Dosing #Renal ... Impairment #CKD #Table
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... #antidiabeticagents ... Glucose-lowering medication ... Canagliflozin on Renal ... outcomes trials; DPP
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... events TZDs DPP ... EricsMedicalLectures/featured #diabetes ... #medications #table
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Sulfonylurea, TZD, DPP ... insulin dose for renal ... DM2 #Inpatient #Medications ... pharmacology #comparison #table